US Stock MarketDetailed Quotes

MLYS Mineralys Therapeutics

Watchlist
  • 8.760
  • -0.490-5.30%
Close Feb 25 16:00 ET
  • 9.990
  • +1.230+14.04%
Pre 06:15 ET
436.56MMarket Cap-2.39P/E (TTM)

Mineralys Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
127.27%192.4M
86.81%51.77M
128.77%60.11M
187.05%45.17M
136.73%35.36M
168.93%84.66M
176.89%27.71M
253.94%26.27M
142.86%15.74M
97.36%14.94M
Selling and administrative expenses
66.63%23.82M
78.79%7.2M
62.19%6.12M
53.08%5.9M
74.22%4.61M
173.40%14.3M
83.84%4.03M
176.69%3.77M
335.63%3.85M
234.39%2.65M
-General and administrative expense
66.63%23.82M
78.79%7.2M
62.19%6.12M
53.08%5.9M
74.22%4.61M
173.40%14.3M
83.84%4.03M
176.69%3.77M
335.63%3.85M
234.39%2.65M
Research and development costs
139.59%168.58M
88.17%44.57M
139.94%53.99M
230.47%39.27M
150.17%30.75M
168.04%70.36M
202.95%23.69M
271.33%22.5M
112.40%11.88M
81.37%12.29M
Operating profit
-127.27%-192.4M
-86.81%-51.77M
-128.77%-60.11M
-187.05%-45.17M
-136.73%-35.36M
-168.93%-84.66M
-176.89%-27.71M
-253.94%-26.27M
-142.86%-15.74M
-97.36%-14.94M
Net non-operating interest income expense
14.36%14.59M
-15.42%2.81M
7.43%3.77M
15.56%4.15M
65.44%3.85M
661.10%12.76M
255.19%3.32M
374.09%3.51M
3.59M
2.33M
Non-operating interest income
14.36%14.59M
-15.42%2.81M
7.43%3.77M
15.56%4.15M
65.44%3.85M
661.10%12.76M
255.19%3.32M
374.09%3.51M
--3.59M
--2.33M
Other net income (expense)
66.67%5K
1,100.00%12K
-10K
100.00%2K
0.00%1K
-25.00%3K
1K
1K
1K
Other non- operating income (expenses)
66.67%5K
1,100.00%12K
---10K
100.00%2K
0.00%1K
-25.00%3K
--1K
----
--1K
--1K
Income before tax
-147.31%-177.81M
-100.69%-48.95M
-147.55%-56.34M
-237.81%-41.01M
-149.90%-31.51M
-141.28%-71.9M
-168.81%-24.39M
-240.82%-22.76M
-87.39%-12.14M
-66.57%-12.61M
Income tax
Net income
-147.31%-177.81M
-100.69%-48.95M
-147.55%-56.34M
-237.81%-41.01M
-149.90%-31.51M
-141.28%-71.9M
-168.81%-24.39M
-240.82%-22.76M
-87.39%-12.14M
-66.57%-12.61M
Net income continuous Operations
-147.31%-177.81M
-100.69%-48.95M
-147.55%-56.34M
-237.81%-41.01M
-149.90%-31.51M
-141.28%-71.9M
-168.81%-24.39M
-240.82%-22.76M
-87.39%-12.14M
-66.57%-12.61M
Minority interest income
Net income attributable to the parent company
-147.31%-177.81M
-100.69%-48.95M
-147.55%-56.34M
-237.81%-41.01M
-149.90%-31.51M
-141.28%-71.9M
-168.81%-24.39M
-240.82%-22.76M
-87.39%-12.14M
-66.57%-12.61M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-147.31%-177.81M
-100.69%-48.95M
-147.55%-56.34M
-237.81%-41.01M
-149.90%-31.51M
-141.28%-71.9M
-168.81%-24.39M
-240.82%-22.76M
-87.39%-12.14M
-66.57%-12.61M
Basic earnings per share
-83.92%-3.66
-55.56%-0.98
-98.25%-1.13
-167.74%-0.83
-37.25%-0.7
-160.82%-1.99
-171.20%-0.63
55.81%-0.57
75.21%-0.31
65.09%-0.51
Diluted earnings per share
-83.92%-3.66
-55.56%-0.98
-98.25%-1.13
-167.74%-0.83
-37.25%-0.7
-160.82%-1.99
-171.20%-0.63
55.81%-0.57
75.21%-0.31
65.09%-0.51
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 127.27%192.4M86.81%51.77M128.77%60.11M187.05%45.17M136.73%35.36M168.93%84.66M176.89%27.71M253.94%26.27M142.86%15.74M97.36%14.94M
Selling and administrative expenses 66.63%23.82M78.79%7.2M62.19%6.12M53.08%5.9M74.22%4.61M173.40%14.3M83.84%4.03M176.69%3.77M335.63%3.85M234.39%2.65M
-General and administrative expense 66.63%23.82M78.79%7.2M62.19%6.12M53.08%5.9M74.22%4.61M173.40%14.3M83.84%4.03M176.69%3.77M335.63%3.85M234.39%2.65M
Research and development costs 139.59%168.58M88.17%44.57M139.94%53.99M230.47%39.27M150.17%30.75M168.04%70.36M202.95%23.69M271.33%22.5M112.40%11.88M81.37%12.29M
Operating profit -127.27%-192.4M-86.81%-51.77M-128.77%-60.11M-187.05%-45.17M-136.73%-35.36M-168.93%-84.66M-176.89%-27.71M-253.94%-26.27M-142.86%-15.74M-97.36%-14.94M
Net non-operating interest income expense 14.36%14.59M-15.42%2.81M7.43%3.77M15.56%4.15M65.44%3.85M661.10%12.76M255.19%3.32M374.09%3.51M3.59M2.33M
Non-operating interest income 14.36%14.59M-15.42%2.81M7.43%3.77M15.56%4.15M65.44%3.85M661.10%12.76M255.19%3.32M374.09%3.51M--3.59M--2.33M
Other net income (expense) 66.67%5K1,100.00%12K-10K100.00%2K0.00%1K-25.00%3K1K1K1K
Other non- operating income (expenses) 66.67%5K1,100.00%12K---10K100.00%2K0.00%1K-25.00%3K--1K------1K--1K
Income before tax -147.31%-177.81M-100.69%-48.95M-147.55%-56.34M-237.81%-41.01M-149.90%-31.51M-141.28%-71.9M-168.81%-24.39M-240.82%-22.76M-87.39%-12.14M-66.57%-12.61M
Income tax
Net income -147.31%-177.81M-100.69%-48.95M-147.55%-56.34M-237.81%-41.01M-149.90%-31.51M-141.28%-71.9M-168.81%-24.39M-240.82%-22.76M-87.39%-12.14M-66.57%-12.61M
Net income continuous Operations -147.31%-177.81M-100.69%-48.95M-147.55%-56.34M-237.81%-41.01M-149.90%-31.51M-141.28%-71.9M-168.81%-24.39M-240.82%-22.76M-87.39%-12.14M-66.57%-12.61M
Minority interest income
Net income attributable to the parent company -147.31%-177.81M-100.69%-48.95M-147.55%-56.34M-237.81%-41.01M-149.90%-31.51M-141.28%-71.9M-168.81%-24.39M-240.82%-22.76M-87.39%-12.14M-66.57%-12.61M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -147.31%-177.81M-100.69%-48.95M-147.55%-56.34M-237.81%-41.01M-149.90%-31.51M-141.28%-71.9M-168.81%-24.39M-240.82%-22.76M-87.39%-12.14M-66.57%-12.61M
Basic earnings per share -83.92%-3.66-55.56%-0.98-98.25%-1.13-167.74%-0.83-37.25%-0.7-160.82%-1.99-171.20%-0.6355.81%-0.5775.21%-0.3165.09%-0.51
Diluted earnings per share -83.92%-3.66-55.56%-0.98-98.25%-1.13-167.74%-0.83-37.25%-0.7-160.82%-1.99-171.20%-0.6355.81%-0.5775.21%-0.3165.09%-0.51
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
FRMO CORP
FRMO
-0.89%
The9 Ltd
NCTY
-2.31%
Argo Blockchain
ARBK
-3.11%
Ebang International
EBON
-3.32%
Intchains Group
ICG
-4.52%

Unlock the Full List